A drug given by mouth for the treatment of chronic gout. The main side-effects are nausea and abdominal pain; the drug may also activate a latent duodenal ulcer and it should not be taken by patients with impaired kidney function.
A derivative of phenylbutazone which is of value in the prophylaxis and treatment of gout.
A medication used to address hyperuricemia by enhancing the elimination of urate through urine.
A medication employed to decrease the occurrence of gout attacks. Sulfinpyrazone’s potential adverse effects encompass feelings of nausea and abdominal discomfort.